BioSpace News Archive

Rising Prevalence Of Diabetes And Increasing Preference For Home-Care Settings Are Key Factors Driving Point-Of-Care Glucose Testing Market Growth

Rising prevalence of diabetes and glucose impairment, growing preference for homecare settings, and rising need to monitor and control diabetes are key factors driving market growth.

April 18, 2022
·
7 min read
Pharm Country

iHealthScreen Inc. Announces Australian Health (TGA) Approval for iPredictTM Automated AI System for Early Diagnosis of Diabetic Retinopathy (DR), Age-Related Macular degeneration (AMD), and Glaucoma Suspect

iPredictTM AI Eye Screening System provides fully automated diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results.

April 18, 2022
·
2 min read
Breast Cancer Drugs Market: New research activities show links between breast cancer drugs and other health conditions

Designated drug treatment utilizes meds that are aimed at (target) proteins on bosom disease cells that assist them with developing, spread, and live longer.

April 18, 2022
·
2 min read
Increase in Adoption of Human Cell for Therapeutics Studies Promotes the Cell Therapy Industry

According to Allied Market Research, the global cell therapy market is anticipated to display a striking CAGR from 2020 to 2027.

April 18, 2022
·
2 min read
Biotech Bay

SI-BONE To Present at BofA Securities 2022 Healthcare Conference

SI-BONE, Inc. announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Conference in Las Vegas.

April 18, 2022
·
1 min read
Biotech Beach

Codex DNA Demonstrates Simple, Scalable, and Cell-Free Approach to Rapid mRNA Vaccine Design and Development at World Vaccine Congress Washington 2022

Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker presentation for the World Vaccine Congress Washington 2022, which is being held in Washington, DC. on April 18-21, 2022

April 18, 2022
·
4 min read
Business

Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2022

Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2022 on Monday, May 2, 2022, after market close.

April 18, 2022
·
1 min read
Deals

Retractable Technologies, Inc. Announces Termination of Buyback Plan

Retractable Technologies, Inc. (NYSE American: RVP) reports that, effective April 14, 2022, it has terminated its Rule 10b5-1/10b-18 Repurchase Plan dated June 4, 2021.

April 18, 2022
·
2 min read
Deals

Asahi Kasei Medical to Acquire Bionova Scientific, U.S.-based Biopharmaceutical CDMO

Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies.

April 18, 2022
·
3 min read
DNA Sequencing Market Size 2022-2028 - Growing Investments In Cancer Research And Increased Funding By Government And Private Sectors

Technological advancements in DNA sequencing, improvement in healthcare infrastructure and research facilities, and increasing investments in research and development activities are key factors fueling global market growth.

April 18, 2022
·
8 min read